Circulating Lymphocyte Count During Neoadjuvant Chemoradiation Therapy for Esophageal Cancer as a Predictive Biomarker of Pathologic Complete Response

被引:1
|
作者
Jiang, W. [1 ]
Davuluri, R. [2 ]
Fang, P. [1 ]
Xu, C. [3 ]
Welsh, J. W. [4 ]
Crane, C. H. [1 ]
Komaki, R. U. [4 ]
Cox, J. D. [1 ]
Hsu, C. C. [5 ]
Lin, S. H. [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Univ Arizona, Tucson, AZ USA
[3] MD Anderson Canc Ctr, Houston, TX USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA
[5] Univ Arizona, Dept Radiat Oncol, Tucson, AZ 85721 USA
关键词
D O I
10.1016/j.ijrobp.2016.06.366
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
341
引用
收藏
页码:S151 / S151
页数:1
相关论文
共 50 条
  • [41] Neoadjuvant Chemotherapy versus Chemoradiation Prior to Esophagectomy: Impact on Rate of Complete Pathologic Response and Survival in Esophageal Cancer Patients
    Samson, Pamela
    Robinson, Clifford
    Bradley, Jeffrey
    Lockhart, A. Craig
    Puri, Varun
    Broderick, Stephen
    Kreisel, Daniel
    Krupnick, A. Sasha
    Patterson, G. Alexander
    Meyers, Bryan
    Crabtree, Traves
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (12) : 2227 - 2237
  • [42] Neoadjuvant chemotherapy versus chemoradiation prior to esophagectomy: Impact on rate of complete pathologic response and survival in esophageal cancer patients
    Lockhart, Albert C.
    Samson, Pamela Parker
    Robinson, Cliff Grant
    Bradley, Jeffrey D.
    Puri, Varun
    Broderick, Stephen R.
    Patterson, G. Alexander
    Meyers, Bryan F.
    Crabtree, Traves
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [43] Clinical and Pathologic Evaluation of the Effectiveness of Neoadjuvant Chemoradiation Therapy in Advanced Esophageal Cancer Patients
    Akutsu, Yasunori
    Matsubara, Hisahiro
    Shuto, Kiyohiko
    Uesato, Masaya
    Mori, Mikito
    Hoshino, Isamu
    Shiratori, Toru
    Miyazawa, Yukimasa
    Ito, Hisao
    Uno, Takashi
    WORLD JOURNAL OF SURGERY, 2009, 33 (05) : 1002 - 1009
  • [44] Clinical and Pathologic Evaluation of the Effectiveness of Neoadjuvant Chemoradiation Therapy in Advanced Esophageal Cancer Patients
    Yasunori Akutsu
    Hisahiro Matsubara
    Kiyohiko Shuto
    Masaya Uesato
    Mikito Mori
    Isamu Hoshino
    Toru Shiratori
    Yukimasa Miyazawa
    Hisao Ito
    Takashi Uno
    World Journal of Surgery, 2009, 33
  • [45] The impact of proton beam therapy on blood cell count nadir during neoadjuvant chemoradiation therapy for esophageal cancer.
    Shiraishi, Yutaka
    Xu, Cai
    Song, Juhee
    Komaki, Ritsuko
    Hobbs, Brian P.
    Lin, Steven H.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [46] Effect of increasing radiation dose on pathologic complete response in rectal cancer patients treated with neoadjuvant chemoradiation therapy
    Hall, Matthew D.
    Schultheiss, Timothy E.
    Smith, David D.
    Fakih, Marwan G.
    Wong, Jeffrey Y. C.
    Chen, Yi-Jen
    ACTA ONCOLOGICA, 2016, 55 (12) : 1392 - 1399
  • [47] Early Apparent Diffusion Coefficient Change During Neoadjuvant Chemoradiation Predicts Pathologic and Clinical Response in Esophageal Cancer
    Fang, P.
    Hobbs, B.
    Fellman, B. M.
    Son, J. B.
    Ma, J.
    Lin, S. H.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E174 - E174
  • [48] Lymphocyte Trends During Neoadjuvant Chemoradiation Predict Pathologic Complete Response at Time of Surgical Resection of Locally Advanced Rectal Cancers
    Dover, L.
    Dulaney, C.
    McDonald, A.
    Jacob, R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E202 - E202
  • [49] Tri-modality therapy for esophageal cancer: Mucinous histology is associated with decreased pathologic response rates to neoadjuvant chemoradiation therapy
    Kim, C.
    Farmer, M. R.
    Yacoub, J.
    Monjazeb, A.
    Levine, E. A.
    Aklilu, M.
    Geinsinger, K. R.
    Mishra, G.
    Melin, S.
    Blackstock, A. W.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S267 - S267
  • [50] Timing of Esophagectomy after Neoadjuvant Chemoradiation Therapy (nCRT) for Esophageal Cancer (EC) is Associated with Worse Outcomes, without Improvement of Complete Pathologic Response (pCR)
    Giugliano, Danica N.
    Berger, Adam C.
    Keith, Scott W.
    Pucci, Michael J.
    Rosato, Ernest L.
    Evans, Nathaniel R., III
    Palazzo, Francesco
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2016, 223 (04) : E76 - E77